Trademark: 98059119
Status Date
Tuesday, September 24, 2024
Filing Date
Monday, June 26, 2023
Published for Opposition
Tuesday, July 30, 2024
42 Pharmaceutical research and development relating to reproductive health, hormones, and gender dysphoria; scientific research and development relating to reproductive health, hormones, and gender dysphoria; medical research and development relating to reproductive health, hormones, and gender dysphoria
The mark consists of a stylized cross with gender symbols in the center.
Color is not claimed as a feature of the mark.
Jul 28, 2023
New Application Office Supplied Data Entered
Jul 29, 2023
Notice Of Design Search Code E-Mailed
Mar 12, 2024
Assigned To Examiner
Jun 11, 2024
Teas/Email Correspondence Entered
Jun 11, 2024
Correspondence Received In Law Office
Jun 11, 2024
Teas Response To Office Action Received
Mar 12, 2024
Non-Final Action Written
Mar 12, 2024
Non-Final Action E-Mailed
Mar 12, 2024
Notification Of Non-Final Action E-Mailed
Jun 24, 2024
Approved For Pub - Principal Register
Jul 10, 2024
Notification Of Notice Of Publication E-Mailed
Jul 30, 2024
Published For Opposition
Jul 30, 2024
Official Gazette Publication Confirmation E-Mailed
Sep 24, 2024
Noa E-Mailed - Sou Required From Applicant
Trademark Alertz updated from USPTO on 2030-01-24